Unim

Moscow, Russia Founded: 2013 • Age: 13 yrs
Cancer diagnostic services are provided by a standalone center.
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors - Brand Intelligence

About Unim

Unim is a company based in Moscow (Russia) founded in 2013. It operates as a HealthTech and Professional Services. Unim offers products and services including Histological Research, Immunohistochemical Research, and Molecular-Genetic Research.

  • Headquarter Moscow, Russia
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ооо "Юним"
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Medical Devices & Diagnostics → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    IIDF
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Unim

Unim offers a comprehensive portfolio of products and services, including Histological Research, Immunohistochemical Research, and Molecular-Genetic Research.

Primary

Tissue samples are analyzed for cellular abnormalities detection.

Protein markers are studied for precise disease diagnosis.

Genetic mutations are identified for targeted treatment planning.

Funding Insights of Unim

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2013 Amount Seed - Unim Valuation

investors
IIDF

Investors in Unim

Unim has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include IIDF.

All
Venture Fund
Investor Description Founded Year Domain Location
IIDF
Venture capital and startup accelerator focused on multiple sectors
Founded Year Domain Location

Investments & Acquisitions by Unim

Investments

Financial Statements - Unim

Unim Comparisons

+
Add Comparison
Available on Premium

Competitors of Unim

Latest news on Unim

Frequently Asked Questions about Unim

Unim was founded in 2013.

Unim is headquartered in Moscow, Russia.

Unim is established as the first digital pathology laboratory in Russia and the third worldwide. It is specialized in providing a wide range of diagnostic services including histological, immunohistochemical, and molecular-genetic research. Services are offered to both patients and medical professionals across various medical fields such as gynecology, hematology, and oncology. Innovative IT solutions are developed and implemented for enhanced diagnostic accuracy. Scientific research in histology and veterinary fields is also conducted. Modern technologies and standards are utilized to ensure high-quality, fast, and accessible diagnostics for patients.

Unim offers Histological Research, Immunohistochemical Research, and Molecular-Genetic Research.

Unim has 1 investor. Key investors include IIDF.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available